Cern Corporation – Developing a much-needed, non-drug therapy, for mitigation of yeast & bacterial vaginosis (without the need for drugs), is excited to welcome new key members to the team. Dr. Neal Lonky, OBGYN, MPH – Dr. Lonky is a recognized leader…
Cern Corporation has been selected as a finalist for OctaneOC’s prestigious “Best Innovation in Medtech / Device” category ✨ Tech Innovators, Visionaries, and Game-Changers—The wait is over! The finalists for the 2024 High Tech Awards have been selected, and they’re…
The newest episode of the Femtech Health Podcast is live! Listen to the episode here In this episode, we’re joined by Dr. Melanie Santos, a urogynecologist specializing in pelvic floor disorders and reconstruction. She is also the Medical Director of Pelvic Health…
Light Therapy for Vaginitis – Cern’s Drug Free Revolution with Dr. Melanie Santos – FemTech Focus
Cern Corporation is featured in Clinical Trial Vanguard, where our Chief Medical Officer, Dr. Melanie Santos, discusses our Cern Device, a new non-drug, light-based therapy designed to address bacterial vaginosis and fungal vaginitis. This innovative approach combines treatment and diagnostics to…
New York, NY – November 5, 2025 — HITLAB, a global leader in digital health innovation and evidence generation, today announced a strategic partnership with Cern Corporation, Inc., a pioneering women’s health technology company headquartered in Southern California. The collaboration aims to…
Dr. Zibners is Co-Founder and Chairman of Calla Lily Clinical Care and a long-time advocate for innovation in women’s health. As a physician and entrepreneur operating across the U.S. and Europe, she brings a global lens to commercialization strategy and platform growth.…